Ligand Pharmaceuticals | LGND - 营业费用



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 115.08M
销售成本
USD 11.37M
流动资产
USD 865.42M
流动负债
USD 40.67M
债务
USD 451.49M
EBIT
USD 60.33M
EBITDA
USD 66.78M
员工
68
EPS每股收益
USD 1.63
股本和储备
USD 997.32M
销售毛利
USD 48.45M
债务利息支出
USD 1.79M
利息收入
USD 6.39M
贷款资金
USD 446.19M
市值
USD 5.66B
净收入
USD -13.35M
营业费用
USD 34.35M
营业利润
USD 60.33M
普通股股本
USD 19.66M
PE价格收益
56.5
税前利润
USD 56.78M
销售收入
USD 51.72M
销售和管理费用
USD 20.84M
股票
USD 13.27M
贸易债权人
USD 37.11M
应收帐款人
USD 54.8M


营业费用 更改 日
Agenus USD -221.22M 241.03M 2026-03
Amgen USD 4.78B 1.12B 2026-03
Anika Therapeutics USD 133.9M 103.93M 2026-03
Arrowhead Research USD 215M 8.23M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Enviri Corporation USD 233.18M 357.11M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Glaxosmithkline GBP 5.34B 3.83B 2026-03
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 506.24M 7.31M 2026-03
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 364M 54M 2026-03
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Ligand Pharmaceuticals USD 34.35M 5.27M 2026-03
MacroGenics USD 21.2M 32.13M 2026-03
Merck USD 18.17B 8.01B 2026-03
Pacira USD 172.75M 20.93M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Veracyte USD 119.99M 3.99M 2026-03